Such a parallel system frequently results in a prolonged infringement proceeding, and inconsistent results. 这种并行机制经常导致侵权诉讼程序历时较长以及诉讼结果不一致。
Patent infringement litigation between Pfizer and Ranbaxy over Lipitor will continue in Finland, Spain, Portugal, Denmark and Romania. 专利侵权诉讼之间的辉瑞和兰伯西超过立普妥将继续在芬兰，西班牙，葡萄牙，丹麦和罗马尼亚。
